Amphastar Pharmaceuticals (AMPH) News Today → Breaking - The US Gov. Seized CITGO (From Augury Research) (Ad) Free AMPH Stock Alerts $40.71 -0.24 (-0.59%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 7 at 5:46 PM | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Epoch Investment Partners Inc.Epoch Investment Partners Inc. lifted its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 348.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 592,530 shares of the company's stock afJune 7 at 6:46 AM | insidertrades.comFloyd F. Petersen Sells 500 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) StockJune 5 at 8:01 PM | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Floyd F. Petersen Sells 500 SharesAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) Director Floyd F. Petersen sold 500 shares of the business's stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $42.65, for a total transaction of $21,325.00. Following the completion of the sale, the director now owns 78,333 shares in the company, valued at $3,340,902.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.June 4, 2024 | americanbankingnews.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Short Interest Down 5.5% in MayJune 3, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by US Bancorp DEUS Bancorp DE boosted its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 2,648.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 21,248 shares of the company's stock after purchasJune 2, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Short Interest UpdateAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) was the recipient of a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 3,770,000 shares, a drop of 5.5% from the April 30th total of 3,990,000 shares. Based on an average trading volume of 410,500 shares, the short-interest ratio is currently 9.2 days. Currently, 10.7% of the shares of the company are sold short.May 31, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Acquired by TD Asset Management IncTD Asset Management Inc boosted its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 449.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 793,559 shares of the company's stocMay 30, 2024 | seekingalpha.comAmphastar Pharmaceuticals: Buy When Fear Is OverblownMay 28, 2024 | stocknews.com4 Pharma Stocks to Watch for Surprising Gains in JuneMay 27, 2024 | marketbeat.comCapital One Financial Analysts Boost Earnings Estimates for Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) - Capital One Financial increased their Q2 2024 earnings per share estimates for Amphastar Pharmaceuticals in a research note issued on Wednesday, May 22nd. Capital One Financial analyst T. Chiang now expects that the company will post eMay 26, 2024 | marketbeat.comTrexquant Investment LP Buys Shares of 38,959 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Trexquant Investment LP bought a new stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 38,959 shares of the comMay 25, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Increases Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Charles Schwab Investment Management Inc. lifted its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 7.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 379,480 shares of the company's stock afMay 25, 2024 | finance.yahoo.comAmphastar Pharmaceuticals, Inc. (AMPH)May 24, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Dimensional Fund Advisors LPDimensional Fund Advisors LP reduced its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 29.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,339,142 shares of the company's stock aMay 22, 2024 | markets.businessinsider.comAmphastar Pharmaceuticals Holds Steady Amidst New Approval and Competitive MarketMay 22, 2024 | marketbeat.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Trading Up 4.6%Amphastar Pharmaceuticals (NASDAQ:AMPH) Trading 4.6% HigherMay 22, 2024 | marketbeat.comAmphastar Pharmaceuticals' (AMPH) Hold Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC reaffirmed a "hold" rating on shares of Amphastar Pharmaceuticals in a report on Wednesday.May 22, 2024 | finanznachrichten.deAmphastar Pharmaceuticals, Inc.: Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation AerosolMay 22, 2024 | finance.yahoo.comAmphastar Receives FDA Approval for Albuterol Sulfate Inhalation AerosolMay 20, 2024 | seekingalpha.comAmphastar Pharmaceuticals: Profitable Pharma With Strong GrowthMay 20, 2024 | marketbeat.comBNP Paribas Financial Markets Cuts Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)BNP Paribas Financial Markets lowered its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 20.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 97,806 shares of the company's stock after seMay 16, 2024 | investorplace.comPatent Peril: 3 Stocks at Risk From the FTC's Drug CrusadeMay 15, 2024 | seekingalpha.comReassessing Amphastar PharmaceuticalsMay 15, 2024 | finance.yahoo.comImplied Volatility Surging for Amphastar (AMPH) Stock OptionsMay 13, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), Globus Medical (GMED) and DENTSPLY SIRONA (XRAY)May 12, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Russell Investments Group Ltd.Russell Investments Group Ltd. reduced its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 51.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 63,667 shares of the company's stock aMay 11, 2024 | marketbeat.comMesirow Institutional Investment Management Inc. Raises Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Mesirow Institutional Investment Management Inc. raised its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 37.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 252,8May 10, 2024 | finance.yahoo.comAmphastar Pharmaceuticals Reports Strong First Quarter Earnings, Surpassing Analyst Revenue ...May 10, 2024 | finance.yahoo.comAmphastar Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.90 (vs US$0.54 in 1Q 2023)May 9, 2024 | finanznachrichten.deAmphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care ConferenceMay 9, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Amphastar Pharmaceuticals (AMPH) and Erasca (ERAS)May 9, 2024 | markets.businessinsider.comAmphastar Pharmaceuticals: Hold Rating Justified Amidst Growth Prospects and Pipeline PotentialMay 9, 2024 | insidermonkey.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call TranscriptMay 9, 2024 | marketbeat.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Up to $42.21Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Up to $42.21May 9, 2024 | finance.yahoo.comAmphastar Pharmaceuticals Inc (AMPH) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...May 9, 2024 | finance.yahoo.comQ1 2024 Amphastar Pharmaceuticals Inc Earnings CallMay 9, 2024 | marketbeat.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Receives Hold Rating from Needham & Company LLCNeedham & Company LLC restated a "hold" rating on shares of Amphastar Pharmaceuticals in a report on Thursday.May 8, 2024 | investorplace.comAMPH Stock Earnings: Amphastar Pharma Beats EPS, Misses Revenue for Q1 2024May 8, 2024 | washingtonpost.comAmphastar: Q1 Earnings SnapshotMay 7, 2024 | markets.businessinsider.comWhat Wall Street expects from Amphastar Pharmaceuticals's earningsMay 7, 2024 | marketbeat.comLSV Asset Management Has $19.64 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)LSV Asset Management boosted its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 49.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 317,600 shares of the company's stock aftMay 1, 2024 | marketbeat.comAmphastar Pharmaceuticals (AMPH) Scheduled to Post Quarterly Earnings on WednesdayAmphastar Pharmaceuticals (NASDAQ:AMPH) will be releasing earnings after the market closes on Wednesday, May 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=418090)May 1, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Sees Large Increase in Short InterestAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) saw a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 3,870,000 shares, a growth of 5.4% from the March 31st total of 3,670,000 shares. Based on an average daily volume of 430,500 shares, the short-interest ratio is currently 9.0 days. Approximately 11.0% of the company's stock are sold short.April 30, 2024 | finance.yahoo.comAmphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024April 30, 2024 | msn.comFTC Targets ‘Junk’ Patent Listings on Ozempic and Other DrugsApril 24, 2024 | marketbeat.comLouisiana State Employees Retirement System Takes $1.16 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Louisiana State Employees Retirement System bought a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 18,700 shareApril 22, 2024 | marketbeat.comCalamos Advisors LLC Takes Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Calamos Advisors LLC purchased a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 19,479 shares of the company's stock, valued at approximatelyApril 19, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Forecasted to Post FY2024 Earnings of $3.48 Per ShareAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) - Stock analysts at Capital One Financial raised their FY2024 earnings per share estimates for Amphastar Pharmaceuticals in a report released on Wednesday, April 17th. Capital One Financial analyst T. Chiang now forecasts that the companApril 18, 2024 | marketbeat.comFederated Hermes Inc. Has $202.42 Million Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Federated Hermes Inc. decreased its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 4.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,272,761 shares of the company's stock after sellingApril 18, 2024 | marketbeat.comEquities Analysts Offer Predictions for Amphastar Pharmaceuticals, Inc.'s Q1 2024 Earnings (NASDAQ:AMPH)Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) - Equities researchers at Capital One Financial issued their Q1 2024 earnings per share estimates for shares of Amphastar Pharmaceuticals in a research report issued on Wednesday, April 17th. Capital One Financial analyst T. Chiang forec Get Amphastar Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (Ad)Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now. Click here to see it because it’s a SHOCKER… AMPH Media Mentions By Week AMPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMPH News Sentiment▼0.940.73▲Average Medical News Sentiment AMPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMPH Articles This Week▼74▲AMPH Articles Average Week Get Amphastar Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PTGX News Today SNDX News Today CALT News Today PAHC News Today ESPR News Today ENTA News Today INSM News Today ASND News Today CERE News Today LEGN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMPH) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | Sponsored